ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 3001

$1.18M Total Retail Price of All Prescriptions

Rank: 68 out of 3001

871 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 871 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 871 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 15,190 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 1,218 863 1 3
FUROSEMIDE 817 550 2 6
HYDROCODONE-ACETAMINOPHEN 812 340 S3 3 7
METOPROLOL TARTRATE 685 498 4 8
LISINOPRIL 684 416 5 2
SIMVASTATIN 648 415 6 1
HYDROCHLOROTHIAZIDE 607 463 7 10
OMEPRAZOLE 588 405 8 4
METFORMIN HCL 434 229 9 9
WARFARIN SODIUM 409 358 10 12
OXYCODONE-ACETAMINOPHEN 391 188 S2 11 32
AMLODIPINE BESYLATE 383 276 12 5
SERTRALINE HCL 381 260 13 20
ZOLPIDEM TARTRATE 327 196 14 24
DONEPEZIL HCL 309 272 15 27
CITALOPRAM HBR 267 191 16 16
NEXIUM 253 147 17 23
GABAPENTIN 240 140 18 14
METOPROLOL SUCCINATE 233 191 19 19
DIOVAN 223 171 20 50
PROAIR HFA 204 79 21 30
PANTOPRAZOLE SODIUM 199 164 22 43
TRAMADOL HCL 195 120 23 17
ATORVASTATIN CALCIUM 192 122 24 11
POLYETHYLENE GLYCOL 3350 188 174 25 55
FENTANYL 186 129 S2 26 76
AZITHROMYCIN 183 93 27 36
MIRTAZAPINE 173 159 28 44
CIPROFLOXACIN HCL 173 132 28 56
NAMENDA 172 172 30 40
POTASSIUM CHLORIDE 170 122 31 15
LOVASTATIN 161 100 32 38
ATENOLOL 159 88 33 18
SULFAMETHOXAZOLE-TRIMETHOPRIM 157 108 34 77
NAPROXEN 151 48 35 84
CRESTOR 149 98 36 33
CARVEDILOL 144 122 37 25
CLOPIDOGREL 131 111 38 28
OXYCODONE HCL 130 0 S2 39 72
CYMBALTA 130 72 39 53
KLOR-CON M20 120 69 41 52
RANITIDINE HCL 119 77 42 41
DIVALPROEX SODIUM 115 79 43 70
PLAVIX 114 92 44 46
CYCLOBENZAPRINE HCL 111 36 R 45 73
TAMSULOSIN HCL 110 93 46 29
ALLOPURINOL 109 95 47 35
FLUTICASONE PROPIONATE 106 81 48 42
ALENDRONATE SODIUM 104 45 49 26
LOSARTAN POTASSIUM 101 79 50 21
TRIAMCINOLONE ACETONIDE 101 51 50 159
PRAVASTATIN SODIUM 101 65 50 13
DIGOXIN 100 95 53 65
OXYBUTYNIN CHLORIDE ER 99 27 54 79
SPIRONOLACTONE 99 83 54 75
TRAZODONE HCL 99 50 54 37
LANTUS SOLOSTAR 97 62 57 80
PAROXETINE HCL 93 46 58 60
RISPERIDONE 92 63 59 63
LANTUS 91 57 60 47
OXYCODONE HCL-ACETAMINOPHEN 90 18 S2 61 81
MORPHINE SULFATE ER 89 28 S2 62 150
ZETIA 87 71 63 69
PHENYTOIN SODIUM EXTENDED 87 19 63 126
PROMETHAZINE HCL 81 41 R 65 93
OXYCONTIN 79 31 S2 66 129
GLIPIZIDE 79 64 66 67
ADVAIR DISKUS 78 45 68 58
NOVOLOG 77 62 69 94
GLIPIZIDE ER 76 48 70 130
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 55 71 22
ISOSORBIDE MONONITRATE ER 75 57 71 45
ENDOCET 75 25 S2 71 165
KLOR-CON 10 74 65 74 160
GLYBURIDE 74 60 R 74 62
GLIPIZIDE XL 73 50 76 182
MELOXICAM 72 66 77 34
METHYLPREDNISOLONE 71 39 78 121
TOPIRAMATE 71 0 78 156
IPRATROPIUM-ALBUTEROL 70 70 80 119
DOXYCYCLINE HYCLATE 70 51 80 105
SYNTHROID 70 51 80 71
AMITRIPTYLINE HCL 69 52 R 83 85
PEN NEEDLE 68 23 84 128
LYRICA 67 46 85 87
NITROFURANTOIN MONO-MACRO 67 49 85 158
LEVOFLOXACIN 65 57 87 115
CARISOPRODOL 65 0 R 87 157
ACTOS 64 31 89 113
HUMALOG 63 40 90 207
ENALAPRIL MALEATE 62 60 91 83
PREDNISONE 62 46 91 39
INSULIN SYRINGE 61 37 93 162
CLONIDINE HCL 59 27 94 64
CARBIDOPA-LEVODOPA 58 54 95 97
PROPRANOLOL HCL 57 38 96 136
TRICOR 57 47 96 132
HYDROXYZINE PAMOATE 55 15 R 98 218
SPIRIVA 55 25 98 57
DIOVAN HCT 55 33 98 109
FLUCONAZOLE 54 29 101 194
FLUOXETINE HCL 53 22 102 61
TRIAMTERENE-HCTZ 53 43 102 48
DOXAZOSIN MESYLATE 52 52 104 90
SYMBICORT 51 29 105 155
DILTIAZEM 24HR ER 51 33 105 131
NYSTATIN 50 34 107 149
LOSARTAN-HYDROCHLOROTHIAZIDE 50 36 107 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.